Pharmaceutically efficacious pteridine derivatives
CA 2015049 C · Owner: Christner, Angelika · Inventors: Hofmann, Ingrid; Mutschler, Ernst; Christner, Angelika
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A pharmaceutically efficacious pteridine compound of formula I:, (see fig.I), wherein A denote a bridging hydrocarbon group containing 1 to 8 carbon atoms and containing a (see fig.II) group directly bonded to the phenyl group and one of the methylene radicals of the bridging A group is optionally replaced by -O-;R1 is hydrogen a, cycloalkyl group with up to 7 carbon ring atoms or, an alkyl group having 1 to 6 carbon atoms benzyl, or aryl; R2 is hydrogen or an alkyl group having 1 to 6 carbon atoms, or wherein R1 and R2 together form a five- or six-membered heterocyclic group which optionally contains additional hereto atoms selected from the group consisting of nitrogen, oxygen and, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 20, 1990 and granted October 21, 1997. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 20, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 20, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.